文献速递介入妇产影像MRDSA

可吸收微球与三丙烯酰明胶微球用于子宫动脉栓塞术的随机对照试验

Resorbable Microspheres versus Trisacryl Gelatin Microspheres for Uterine Artery Embolization: A Randomized Controlled Trial.
PubMed 文献 · Radiology · 2024-01-01

本随机对照试验纳入60例症状性子宫肌瘤患者,比较可吸收微球(RMs)与三丙烯酰明胶微球(TAGMs)行子宫动脉栓塞术的疗效与临床结局。两组疼痛评分及24小时芬太尼总用量无显著差异,优势肌瘤完全坏死率均为97%;RMs组子宫动脉再通率高于TAGMs组(70% vs 17%,P < .001)。

要点

  • RMs与TAGMs行子宫动脉栓塞术后24小时疼痛评分及芬太尼用量无显著差异。
  • 两组优势肌瘤完全坏死率均为97%(29/30),无显著差异(P > .99)。
  • RMs组子宫动脉再通率70%(21/30)高于TAGMs组17%(5/30),P < .001。

核心结论

  • 与TAGMs相比,RMs行子宫动脉栓塞术在症状性子宫肌瘤患者中疗效及术后疼痛评分无差异证据,但RMs组子宫动脉再通率更高。

研究设计与样本

  • 随机对照试验,单机构,2021年5月至2023年5月,60例症状性子宫肌瘤患者随机1:1分为RMs组与TAGMs组各30例,术前及术后3个月行MRI评估。

关键影像表现/征象

  • MRI于术前及术后3个月评估肌瘤坏死与子宫动脉再通,两组优势肌瘤完全坏死率均为97%(29/30)。
  • RMs组子宫动脉再通率70%(21/30),TAGMs组17%(5/30),P < .001。

诊断标准与关键数值

  • 优势肌瘤完全坏死率:RMs组97%(29/30)vs TAGMs组97%(29/30),P > .99。
  • 子宫动脉再通率:RMs组70%(21/30)vs TAGMs组17%(5/30),P < .001。
  • 24小时芬太尼总用量中位数:RMs组423(IQR 330-530)vs TAGMs组562(IQR 437-780),P = .15。
  • 术后3个月血清抗苗勒管激素:RMs组0.71 ng/mL ± 0.73 vs TAGMs组0.49 ng/mL ± 0.45,P = .09。
  • 疼痛评分两组无差异证据(P > .99)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background There are insufficient data comparing resorbable microspheres (RMs) with permanent trisacryl gelatin microspheres (TAGMs) for uterine artery embolization (UAE). Purpose To compare therapeutic efficacy and clinical outcomes in participants with symptomatic fibroids after UAE with RMs or TAGMs. Materials and Methods This randomized controlled trial included participants undergoing UAE for symptomatic fibroids at a single institution (from May 2021 to May 2023). Participants were randomized one-to-one to undergo UAE with either RMs or TAGMs. Numeric rating scale pain scores and cumulative fentanyl consumption were assessed for 24 hours after undergoing UAE. Anti-Mullerian hormone was measured to assess effects of UAE on ovarian function. MRI was performed before and 3 months after UAE to evaluate fibroid necrosis and uterine artery recanalization. Repeated variables such as pain were analyzed using Mann-Whitney U test with post hoc Bonferroni correction. Results Sixty female participants (mean age, 45.7 years ± 3.6 [SD]) completed the study, with 30 in each group. No evidence of a difference in pain scores was observed between groups (P > .99). Moreover, there was no evidence of a difference in the total fentanyl consumption at 24 hours after UAE between groups (median: RMs, 423 [IQR, 330-530] vs TAGMs, 562 [IQR, 437-780]; P = .15). Serum anti-Mullerian hormone 3 months after UAE showed no evidence of a difference between groups (RMs vs TAGMs, 0.71 ng/mL ± 0.73 vs 0.49 ng/mL ± 0.45, respectively; P = .09). No evidence of a difference in the rate of complete necrosis of the dominant fibroid was observed between groups (97% [29 of 30] for both groups; P > .99). The rate of uterine artery recanalization was higher in RM versus TAGM groups (70% [21 of 30] vs 17% [five of 30], respectively; P < .001). Conclusion UAE with RMs, compared with UAE with TAGMs, showed no evidence of a difference in terms of therapeutic effectiveness or postprocedural pain scores in participants with symptomatic fibroids. Clinical trial registration no. NCT05086770 © RSNA, 2024 See also the editorial by Spies in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Han K, Kim SY, Kim MD, et al. Resorbable Microspheres versus Trisacryl Gelatin Microspheres for Uterine Artery Embolization: A Randomized Controlled Trial. Radiology. 2024. PMID: 39254451. doi:10.1148/radiol.231525

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。